Burlingame

Hill+Knowlton acquires JeffreyGroup in Latin America, strengthens technology offering with global expansion of the Ideal brand

Retrieved on: 
Wednesday, September 21, 2022
Telecommunications, Public Relations, Investor Relations, Marketing, Communications, Professional Services, Technology, Other Technology, Business, Salesforce, Marriott International, Time, Twitter, Creativity, Burlingame, LinkedIn, Acquisition, Growth, Industry, Provocation, Facebook, Johnson & Johnson, Paulo, CEO, WPP, 2005 Forbes Global CEO Conference, Technology, AstraZeneca, Appetite, Family, Leadership, Annamaria, TikTok, BlackRock, Amazon, Walt Disney World, Innovation, View, Renewable energy, Airline, Public relations, Retail, Bayer, Hill+Knowlton Strategies, American Airlines

Recently, JeffreyGroup earned more nominations than any other agency in PRovoke Medias upcoming 2022 Latin America SABRE Awards.

Key Points: 
  • Recently, JeffreyGroup earned more nominations than any other agency in PRovoke Medias upcoming 2022 Latin America SABRE Awards.
  • JeffreyGroup will continue to operate its distinct brand in Latin America as a part of Hill+Knowlton.
  • Ricardo Cesar, who has led H+Ks Latin American operations since 2018, has been promoted to Global CEO, Ideal, and charged with taking the Ideal brand and business model to a global market.
  • Working with Sara and the global tech team, Ideal will help amplify H+Ks already impressive technology communications reputation globally.

The Exceptional Women Awardees Foundation (EWA) announces selection of Jannies Burlingame, Chief Financial Officer, Aptera Motors, as a Winter 2022 Awardee

Retrieved on: 
Wednesday, May 4, 2022
Atmosphere, Burlingame, San Diego Business Journal, Risk management, Woman, Travel, Government, J-SOX, EWA, CFO, Exceptional Women in Publishing, Jannie Chan, Compliance, CFO (magazine), Efficiency, Emotion, LOS, Grade (consulting), Aptera Motors, Sarbanes–Oxley Act, Solution, Technology, CEO, COSO, SS, Growth, Mentorship, World Bank Governance Surveys, Cultural intelligence, Risk, SEV (company), Pharmaceutical industry, Audit, Management, Telecommunication, Aptera, Entertainment

LOS ANGELES, May 4, 2022 /PRNewswire-PRWeb/ -- The Exceptional Women Awardees Foundation (EWA) announces that after an expansive search Jannies Burlingame, Chief Financial Officer, Aptera Motors was selected for the Winter 2022 EWA Cohort and was recently honored with San Diego Business Journal's CFO of the Year for Small Private Company.

Key Points: 
  • The Exceptional Women Awardees Foundation (EWA) announces that after an expansive search Jannies Burlingame, Chief Financial Officer, Aptera Motors was selected for the Winter 2022 EWA Cohort and was recently honored with San Diego Business Journal's CFO of the Year for Small Private Company.
  • LOS ANGELES, May 4, 2022 /PRNewswire-PRWeb/ -- The Exceptional Women Awardees Foundation (EWA) announces that after an expansive search Jannies Burlingame, Chief Financial Officer, Aptera Motors was selected for the Winter 2022 EWA Cohort and was recently honored with San Diego Business Journal's CFO of the Year for Small Private Company.
  • She also conducted nearly a thousand hours in training courses for global corporations on audit methodology, risk management, Sarbanes-Oxley, and J-SOX.
  • "First, we'd like to congratulate Jannies on being awarded CFO of the Year for Small Private Company!

Proterra Announces Leadership Succession Plan

Retrieved on: 
Thursday, December 9, 2021

BURLINGAME, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Proterra Inc (Nasdaq: PTRA) (“Proterra” or the “Company”), a leading innovator in commercial vehicle electrification technology, today announced that Gareth Joyce, who currently serves as President of Proterra, will succeed Jack Allen as Chief Executive Officer and join the Company’s Board of Directors, effective January 1, 2022. Mr. Allen will retire as CEO and continue to serve on the Company’s Board as Non-Executive Chairman at that time.

Key Points: 
  • Thanks to Jacks leadership, Proterra has a strong foundation in place.
  • During his time with Proterra, Gareth has proven himself as a leader, strong operator and customer-oriented innovator.
  • Ms. Sargent said, The Board would like to thank Ryan for his vision, leadership and service to Proterra.
  • Mr. Joyce has been with Proterra since 2020, most recently serving as President of Proterra.

Frost & Sullivan Recognizes Sentient Energy® with the 2021 Global Grid Line Sensors Company of the Year Award

Retrieved on: 
Thursday, December 9, 2021
Twitter, GLOBE, Energy, Leadership, Safety, Efficiency, Weather, Industry, Achievement, Frost, Ernst & Young Entrepreneur of the Year Award, LinkedIn, Solution, Wildfire, Renewable energy

FRISCO, Texas, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Sentient Energy Inc ., a Koch Engineered Solutions company and the leading provider of advanced grid monitoring and analytics for electric utilities, today announced that they have been awarded the Frost & Sullivan 2021 Global Grid Line Sensors Company of the Year Award.

Key Points: 
  • FRISCO, Texas, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Sentient Energy Inc ., a Koch Engineered Solutions company and the leading provider of advanced grid monitoring and analytics for electric utilities, today announced that they have been awarded the Frost & Sullivan 2021 Global Grid Line Sensors Company of the Year Award.
  • Aging energy infrastructure, widespread deployment of distributed energy resources, extreme weather, and wildfires mean ever-growing complexity for todays grid operators.
  • Sentient Energys Grid Analytics System gives utilities the industrys most comprehensive solution, delivering unparalleled distribution grid visibility, analytics, and predictive insights for greater safety, reliability, and efficiency of the entire distribution grid.
  • Sentient Energy, a Koch Engineered Solutions company, is the premier provider of intelligent sensing, data analytics, optimization, and control technologies for the distribution grid.

Anadolu Isuzu and Proterra announce collaboration for next-generation Citi VOLT battery-electric buses in Europe

Retrieved on: 
Tuesday, November 16, 2021
Efficiency, General manager, Isuzu (Anadolu), NASDAQ, Technology, Transport, Growth, Citigroup, MENA, Silicon, EV, GLOBE, Environment, Solution, NoVOC, Proterra (bus manufacturer), Motor vehicle, Rail transport, Renewable energy

Under the collaboration, Anadolu Isuzu will incorporate Proterras battery technology into its new 12-meter and 18-meter zero-emission Citi VOLT electric bus models.

Key Points: 
  • Under the collaboration, Anadolu Isuzu will incorporate Proterras battery technology into its new 12-meter and 18-meter zero-emission Citi VOLT electric bus models.
  • The Proterra battery system powering the next-generation Citi VOLT electric buses will enable a drive range from 200km to 405km on a single charge to meet the demands of the European public transportation market.
  • Proterra is excited to work with an industry-leader like Anadolu Isuzu to bring our proven battery technology to the European public transportation market.
  • Anadolu Isuzu aims to offer even lower operating costs, longer range and maximum efficiency with its new 12-meter and 18-meter zero-emission Citi VOLT electric bus models.

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Retrieved on: 
Friday, November 12, 2021

BURLINGAME, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced updated results from its Phase 1/1b clinical trial of mupadolimab (formerly CPI-006), a humanized monoclonal antibody directed against CD73 with a proposed unique mechanism of activating B cells to generate immune responses to tumor antigens and viruses, and inhibiting the production of immunosuppressive adenosine in the tumor microenvironment. The clinical data, along with pre-clinical data, further strengthen mupadolimab’s mechanism of action and demonstrate its potential anti-tumor activity in cancer patients.

Key Points: 
  • The clinical data, along with pre-clinical data, further strengthen mupadolimabs mechanism of action and demonstrate its potential anti-tumor activity in cancer patients.
  • The data were made available today in an on-demand, electronic poster format for registered participants of the Society for Immunotherapy of Cancer (SITC) Annual Meeting, which is taking place from November 10 to 14, 2021.
  • These patients will receive the combination of mupadolimab and pembrolizumab and we anticipate reporting results from these expansion cohorts in early 2022.
  • In September, Corvus announced results from its Phase 3 clinical trial of mupadolimab for COVID-19, which have been published online at medRxiv.org.

Proterra Releases Third-Quarter 2021 Financial Results

Retrieved on: 
Wednesday, November 10, 2021
NASDAQ, Standard time, Review, Silicon, EV, Letter, Proterra (bus manufacturer), GLOBE, Solution, Investor relations, Renewable energy

BURLINGAME, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Proterra Inc (NASDAQ: PTRA) has released its third-quarter 2021 financial results by posting them to its Investor Relations website.

Key Points: 
  • BURLINGAME, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Proterra Inc (NASDAQ: PTRA) has released its third-quarter 2021 financial results by posting them to its Investor Relations website.
  • Please visit the Proterra Investor Relations website at ir.proterra.com to view the third-quarter 2021 financial results and letter to shareholders.
  • A conference call will be held at 2:00pm PacificStandard Time on Wednesday, November 10, 2021 to review financial results.
  • Proterra is a leader in the design and manufacture of zero-emission electric transit vehicles and EV technology solutions for commercial applications.

Proterra to supply battery technology for up to 10,000 Lightning eMotors electric commercial vehicles

Retrieved on: 
Wednesday, November 10, 2021
Ambulance, Value chain, Lightning, NASDAQ, Technology, Partnership, Silicon, EV, GLOBE, Solution, Proterra (bus manufacturer), Rail transport

Under a new multi-year supply agreement, Proterra contracted to supply battery systems totaling more than 900 megawatt hours in battery storage capacity to Lightning eMotors to power up to 10,000 electric commercial vehicles between 2022 and 2025.

Key Points: 
  • Under a new multi-year supply agreement, Proterra contracted to supply battery systems totaling more than 900 megawatt hours in battery storage capacity to Lightning eMotors to power up to 10,000 electric commercial vehicles between 2022 and 2025.
  • The expansion builds on Proterras previously announced collaboration with Lightning eMotors to power the Class 3 Lightning Electric Transit commercial van using Proterra battery technology.
  • Proterra will now also supply its battery technology to Lightning eMotors for the Lightning Electric E-450 and Lightning Electric F-550 electric commercial vehicles.
  • Together with Lightning eMotors, were demonstrating how American technology and manufacturing can lead the way towards a future driven by zero-emission, battery-electric commercial vehicles.

Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Retrieved on: 
Wednesday, November 10, 2021
A2A, T-cell lymphoma, ITK, NASDAQ, Conference, Company, GLOBE, CD73, Webcast, Patient, Vaccine

BURLINGAME, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it will present at the Jefferies London Healthcare Conference, which is taking place November 16-19, 2021.

Key Points: 
  • BURLINGAME, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it will present at the Jefferies London Healthcare Conference, which is taking place November 16-19, 2021.
  • A webcast of the presentation will be available via the investor relations section of the Corvus website for 30 days following the event.
  • Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
  • Corvus lead product candidate is mupadolimab (CPI-006), a humanized monoclonal antibody directed against CD73 that has exhibited immunomodulatory activity and activation of immune cells in preclinical studies.

Los Angeles Department of Transportation to Install Solar and Storage Microgrid and EV Charging To Power 100+ Electric Buses with Proterra and Apparent

Retrieved on: 
Friday, November 5, 2021
Adoption, LADOT, Electricity, NASDAQ, CEO, Technology, Transport, Overalls, Investment, Goal, Silicon, EV, GLOBE, City, California Energy Commission, Solution, Climate, Proterra (bus manufacturer), Los Angeles Department of Transportation, Renewable energy

Los Angeles is on track to achieve a zero-emission future and our investments in clean transportation systems are driving that progress, said Mayor Eric Garcetti.

Key Points: 
  • Los Angeles is on track to achieve a zero-emission future and our investments in clean transportation systems are driving that progress, said Mayor Eric Garcetti.
  • The solar and storage microgrid paired with 104 EV chargers will support LADOTs adoption of electric buses as the agency transitions to a fully electric fleet by 2028.
  • LADOT selected Proterra and Apparent to install the EV-charging microgrid at the agencys Washington Bus Yard where it will manage EV charging and overall energy use for more than 100 electric buses.
  • At seven-and-a-half megawatts of EV charging power, the project is one of the largest fleet charging installations in the United States.